We recently reported (Gun. Chem. 28: 1497-1500, 1982)a liquid-chromatographic method for quantifying free cortisol in urine. We have since evaluated the clinical utility of our method by assaying cortisol in urine from normal subjects, patients, and subjects undergoing endocrine tests. We found that, in contrast with plasma cortisol, urinary cortisol is not bound to protein. It shows some correlation with 17-hydroxycorticosteroids in urine, but is independent of creatinine excretion. The amount of cortisol excreted daily by a particular individual was found to be fairly constant during nine or 10 days. Normal values determined for 203 apparently healthy individuals were 35.8 (SD 18.7) .tg/day, with no significant sex-related differences but a tendency for a gradual decrease of cortisol excretion with age. We also report urinary cortisol excretion by patients with pituitary-adrenal disorders and some other diseases, and the pattern of response to dexamethasone and metyrapone administration. Attempts to index the free cortisol concentration in plasma by measuring urinary free cortisol are based on the fact that the free fraction of plasma cortisol is filtered by the renal mechanism, but the protein-bound fraction is not (1).
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Because glomerular filtration and tubular reabsorption are passive and thus concentration-dependent, urinary cortisol is directly related to the free cortisol concentration in plasma. Urinary free cortisol assay is useful because it is believed to reflect the biologically active fraction of this hormone in plasma and it has been shown to facilitate the diagnostic interpretation of pituitary-adrenal disorders (1-
5).
Methods for measuring urinary cortisol include doubleisotope dilution (1-6), fluorometry (7), competitive protein binding (3, 4) , and immunological techniques (8-10). These methods, however, are relatively complicated or require previous extensive purification of cortisol by time consuming chromatography if urinary cortisol is not to be grossly overestimated (11, 12).
By successful application of "high-performance" liquidchromatography to the quantitative determination of cortisol (13), we developed a highly sensitive and specific method for assay of urinary cortisol (14). The specific cortisol fraction can be collected from the column eluate and further separated by a column with different resolution properties. Thus, an organic extract of urine is run through a normalphase column for clean-up, and the cortisol fraction obtained from the eluate is then quantified by liquid chromatography (LC) on a reversed-phase column.
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Here, we report on studies of several problems in the clinical use of urinary cortisol that needed to be solved before routine use of our method.
Materials and Methods
We obtained 24-h urines from 205 apparently healthy volunteers (119 men and 86 women) and from hospitalizedpatients and outpatients with pituitary-adrenal disorders and other diseases. The urines were stored at -20 #{176}C until assay.
The method for quantitative determination of urinary cortisol is essentially based on that previously described (14), except that the mobile phase of the clean-up LC was modified (to dichloromethane/ethanoliwater 96/6/2 by vol) to facilitate the sample clean-up, and thereafter the eluate was collected between 5.7 and 8 mm after sample injection. Under these conditions, the retention times for cortisol and the internal standard are 7.02 and 6.00 mm, respectively.
We used either 1 or 2 mL of urine, extracted with 7 mL of dichioromethane, to measure cortisol concentration, with no remarkable difference in results that was attributable to sample volume.
For simultaneous determination of cortisol and dexamethasone concentration in subjects who had been administered dexamethasone for the suppression te8t, we compared the areas of the peaks obtained on injection of the urine sample (without internal standard) with the cortisol and dexamethasone peak areas obtained when we injected standard urines containing known concentrations of cortisol and dexainethasone. Triplicate urine samples and standard urines that contained cortisolldexamethasone in concentrations of 18.7/20,38.8/40, and 62.3/60 g/L were so measured. Analytical recovery of the two steroids added to urine ranged from 92 to 103% for both cortisol and dexamethasone.
Creatinine and 17-hydroxycorticosteroids in urine were measured according to Bonsnes and Tausaky (15) and Silber and Porter (16), respectively.
For assessment of the response to dexamethasone, four volunteers ingested 0.5 mg of dexamethasone every 6 h for 24 h. Urines were collected on the day before the experiment, on the day of dexamethasone administration, and for the following three days. The effect of metyrapone (Metopirone, SU-4885) on cortisol excretion was studied with five volunteers, who took 500 mg of the drug orally every 4 h for 24 h. Their 24-h urines were collected for four successive days, beginning on the day preceding metyrapone administration.
For ultrafiltration of urine and serum we used an Amicon apparatus with a PM-b filter (Amicon Corp., Lexington, MA) in an ice-cooled water bath.
Results
The clean-up LC can be done sequentially at a fIxed time Figure 1 . cortisol freely passes through a PM-b 0 filter. On the contrary, we found no significant amount of cortisol in the serum ifitrate. Even after incubating serum with urine at 37 #{176}C for 30 mm, there was no effect on the inability of serum cortisol to pass through the filter. Table 2 summaries day-to-day variation of cortisol excretion in 24-h urines from three individuals.
The variation (CV) ranged from 10.0 to b3.2%.
To determine the normal value of cortisol in 24-h urine,
we studied 205apparently healthy volunteers who had been normally active. In two, there was interference with the cortisol peak by other substances, and they were excluded In one case of Cushing's disease, urinary cortisol exceeded the normal reference interval, whereas two cases after roentgenotherapy were only near the upper limit. One case of adrenal hyperplasia showed a very high value. Six patients with brain tumors had values within the normal reference interval.
Other patients with hyperthyroidism, diabetes mellitus, obesity, and hypertension so far examined have not shown abnormal values.
In three patients
with primary aldosteromsm and acromegaly we measured urinary cortisol for several days. A 35-year-old woman was diagnosed as having primary aldosteronism on the basis of the observations of hypertension, hypokalemia, and above-normal aldosterone concentrations. The patient has been administered Trilostane (MWD-1822; 4a,5-epoxy-17-hydroxy-3-oxo-5a-androstane-2a-carbonitrile), a competitive inhibitor for 3I3-hydroxysteroid dehydrogenase, on long-term therapy (240 mg/day). However, her values were not abnormally low, and remained within the normal interval after surgical removal of an adrenal tumor. On the day of the corticotropin test, after intake of ''8ACTH amide (Giractide acetate), 0.35 mg, the value for urinary cortisol was 2.4-fold higher than usual.
One patient, an acromegalic who had been shown to excrete above-normal quantities of cortisol, was normal with regard to concentrations of corticotropin and cortisol in blood. Because most, but not all, of the tumor was removed surgically, the concentration of somatotropin in blood was still high (60-70 pgfL). Urinary cortisol measured on these days was found to be significantly decreased, being within the normal reference interval.
Another acromegalic patient who had a slightly abovenormal concentration of somatotropin was normal with regard to cortisol excretion.
Results of the dexamethasone suppression test done on the four normal subjects are shown in Table 5 . After oral administration of 2 mg of dexamethasone, urinary cortisol was decreased to 23% of the usual. Values were still low on the following day, but thereafter the usual excretions were restored. Dexamethasone was excreted into urine in an The response to the oral metyrapone test was investigated in five normal subjects. Cortisol excretion was inhibited by about 60% on the day of metyrapone administration. On the following two days, excretions of cortisol were greatly increased, reaching b68 and 184% of the usual values. b7-Hydroxycorticosteroids, an indicator of ib-deoxycortisol excretion, appeared in increasing amounts for three days, beginning on the day of metyrapone administration.
Discussion
Given that a small amount of albumin and numerous other plasma proteins is normally excreted into the urine (17-20), some plasma cortisol associated with those plasma proteins may also be excreted in the urine. To investigate this, we carried out a ultrafiltration study on urinary cortisol and found that it can move freely through the filter, indicating that it is not bound to these plasma proteins. If bound to plasma proteins such as cortisol-binding protein and albumin, it could not pass through the ifiter. That the cortisol-protein complex is broken by some urine compo- nents after excretion is not likely, as shown by the negative results after incubation of plasma with urine. These results agree with earlier observations (1, 21) that only the free fraction of plasma cortisol is filtered through the glomerulus and appears in the urine. We also found that the amount of cortisol in the urine depends on the age of the subject. The gradual decrease in urinary cortisol with age may indicate that adrenal func- Some apparently healthy individuals we studied had values exceeding the upper and lower limits of the normal reference interval that was established (see Figure 2) . Those comprised 4% of all the subjects, and they would be candidates for further study.
In some patients without pituitary-adrenal disorders but with obesity, leanness, paraplegia, thyrotoxicosis, liver disease, or who were taking certain drugs, the excretion of 17-hydroxycorticosteroids is often above or below normal, owing to changes in the metabolic clearance rate of cortisol (23) (24) (25) (26) . In contrast, urinary cortisol excretion is independent of these factors (23). This may account for the fairly low correlation observed between urinary cortisol and b7-hydroxycorticosteroids.
No remarkable dependency of urinary cortisol on body size, as reflected in creatinine excretion, was confirmed by the present study.
In one acromegalic studied, urinary cortisol excretion was abnormally high, as has been reported by Lindholm et al. (27) . One patient with primary aldosteronism, who had been treated with Trilostane, an inhibitor for biosynthesis of cortisol and related steroids (28), had normal values for urinary cortisol excretion. Further study is in progress with regard to these particular cases.
Clinical evidence of hypo-and hypercortisolism may be trivial in some patients, indicating the need for simple screening procedures that can be used whenever there is even the mildest clinical suspicion of these conditions. Measurement of 24-h urinary b7-hydroxycorticosteroids show a greater discriminatory power of urinary cortisol values than those described above for diagnostic interpretation in the patients (1-5,29) . Results in our study agree with the observations that the values for urinary cortisol in hypo-and hypercortisolism were outside of the normal reference interval (Table 4) . The values we obtained clearly excluded the diagnosis in groups of patients who have a relatively higher chance of false-positive diagnosis (23-26).
As shown in Table 2 , the urinary cortisol excretion in a particular individual is fairly constant over a nine-or 10-day period, which should facilitate the diagnostic interpretation of the results from suppression and stimulation tests for assessing the normality of the pituitary-adrenal system. Dexamethasone, 2 mg taken orally, decreased the urinary cortisol for two days with a concomitant appearance of its unmetabolized form in urine (Table 5) . A decrease in response to metyrapone was also confirmed in our present study. The observed increase in urinary cortisol on the days after administration may be ascribable to the increased synthesis of cortisol from the excess pool of cortisol precursor, bl-deoxycortisol, after being released from the drug inhibition. The ACTH test applied to a patient (Table 4) showed a good response with respect to the urinary excretion of cortisol.
In contrast with other methods for assaying urinary cortisol, in which two or more different techniques such as RI.A and chromatography are required (8-10), our method involves only the LC technique, and therefore seems to be more simple and practicable.
The method can be used for routine assay of urinary cortisol in the screening of patients and also for endocrine tests with dexamethasone, metyrapone, and corticotropin. 
Liquid-Chromatographic Measurement of Creatinine in Serum and Urine
Takanori Okuda, Takayuki Ole, and Masafumi Nishida
We describe the adaptation of a "high-performance" liquid chromatographic method for determination of creatinine in serum and urine. The proposed method is simple, rapid, precise, and accurate. The retention time for creatinine can be varied simply by changing the KH2P04 concentration in the mobile phase: acetonitrile/aqueous KH2PO4 (1/4 by vol). Within-day precision (CV) was 1.2-3.6% in serum chromatographed with an internal standard, and 2.3-2.8% in serum when an external standard was used. Between-day precision (CV) was 1.3-2.1% in serum and 1.3-2.7% in urine (with an external standard). Analytical recoveries of creatinine added to serum were 94-100% for the method with an internal standard, 95-103% with an external standard.
Creatinine concentrations in biological fluids have long been determined by using the well-known Jaff#{233} reaction (1. Recently, cation-exchange (2-4), adsorption (5, 6), and reversed-phase (7-13) liquid chromatography have been used to determine creatinine free from other interfering biological fluid components. In general, their major advantages are specificity, simplicity, and speed. However, there are several defects: complicated and time-consuming sample treatment
(5-7, 9-13), instability of the exchangers (2-4, 7) , and long column pre-conditioning
(8).
We have now found that varying the retention time of creatinine by changing the KH2PO4 concentration in the mobile phase results in an accurate method for determination of creatinine in serum and urine, a method that is nearly ideal.
Materials and Methods

Apparatus
We used a "high-performance" liquid chromatograph (LC-3A; Shimadzu Corp., Kyoto 604, Japan) equipped with a reversed-phase column (Du Pont Zorbax ODS) 15 cm x 4.6 mm (i.d. 
Reagents
"HPLC-grade" acetonitrile was from Katayama Chemical Industries, Osaka 541, Japan. All other reagents were of reagent grade. We used water produced with a Milli-Q reagent-grade water system (Millipore Corp., Bedford, MA 01730).
Procedures
Sample preparation.
To 0.2 mL of serum or urine (the latter 25-fold diluted with water) or calibrator solution we added 0.4 mL of acetonitrile containing phenacetin (internal standard) 40 mg/L, or only acetonitrile (blank). We vortexmixed the mixture for 10 s, centrifuged at 10 000 rpm for 3 mm, and injected exactly 10 L of the supernate directly into the chromatograph.
Liquid chromatography.
The chromatographic elution was done isocratically with a mobile phase of acetonitrile and 0.1 mmol/L aqueous KH2PO4 (1/4 by vol) at a flow rate of 1.5 mL/min, and a column temperature of 50 #{176}C, in a CTO-2A oven (Shimadzu).
Peak areas on chromatograms were quantified with a data processor (Chromatopac C-R1A; Shimadzu) from measurements of the peak areas and comparison with the peak areas of both the internal standard and the external standard or the absolute calibration.
Results and Discussion
Optimi.zation of mobile phase. In our initial studies, several peaks interfering with determination of creatinine appeared in the beginning on the chromatograms.
We could shift the retention time of creatinine by changing the KH2PO4 content of the mobile phase. However, these changes had no effect on the retention time for phenacetin (Table 1) . For assay of patients' specimens, we chose to use a mobile phase with which creatinine would elute on ODS columns just after phenacetin; this eliminated overlap with other interfering peaks. Figure 1 shows a typical chromatogram of a serum sample containing phenacetin.
Linearity
and sensitivity.
The standard curves were linear up to a creatinine concentration of at least 1 gIL, whether an
